Category:

SRAIC-2026

Gavriela Feketea

by aaaa îăîșț bbbb

Gavriela Feketea

General Hospital of Amaliada, Karamandaneio Children’s Hospital, Patras, Greece

Gavriela Feketea

Dr. Gavriela Feketea is a primary care pediatrician and allergist, Head of the Department of Pediatrics at General Hospital of Amaliada and Coordinator of the Pediatric Allergy Outpatient Clinic at Karamandaneio Children’s Hospital in Patras, Greece.

Her professional and scientific work is focused on pediatric allergology, with a special interest in the diagnosis and management of food allergy and hypersensitivity reactions in children.

She is the author of more than 50 articles published in international peer-reviewed journals, with a Hirsch index of 12 and numerous citations in the literature, mirroring the significant impact of her contributions in the field of clinical allergology and immunology.

She is a member of prestigious academic societies such as the Greek Pediatric Allergy Society (GPAS), the Romanian Society of Allergology and Clinical Immunology and EAACI. She is currently the Treasurer of GPAS and a member of the board of the Allied Health & Primary Care Section of EAACI.

Back

Assoc. Prof. Anca Mirela Chiriac

by aaaa îăîșț bbbb

Assoc. Prof. Anca Mirela Chiriac

University of Montpellier, France

Assoc. Prof. Anca Mirela Chiriac

Associate Professor Anca Mirela Chiriac is a senior allergist and academic at the University of Montpellier, France, where she serves in the Allergy Unit of the University Hospital and is affiliated with the Institut Desbrest d’Épidémiologie et de Santé Publique (IDESP), a joint unit of the University of Montpellier and INSERM.

Her research focuses on drug allergy, particularly the diagnostic utility of drug provocation tests and the development of decision-support tools like the drug allergy numeric card. She was the principal investigator for the Montpellier site of the Horizon 2020 COBIOPHAD project, aimed at developing a diagnostic device for penicillin allergy.

Dr. Chiriac has published over 75 scientific papers and has a Hirsch index of 19. She has contributed as an expert to 10 ENDA/DAIG task forces and guidelines.

Through her clinical expertise and commitment to advancing diagnostic strategies, she continues to play a vital role in improving the management of drug allergies in Europe.

Back

Prof. Rudolf Valenta

by aaaa îăîșț bbbb

Prof. Rudolf Valenta

Medical University of Vienna, Austria

Foreign Adjunct Professor, Karolinska Institutet, Stockholm, Sweden

Prof. Rudolf Valenta

Prof. Rudolf Valenta is a leading personality in allergology and immunology. He earned his M.D. from the Medical University of Vienna in 1987 and has led the Molecular Immunopathology group there since 1993. He is also Foreign Adjunct Professor for Allergy at the Karolinska Institutet.

Prof. Valenta pioneered the use of recombinant allergens in diagnostics and therapy, advancing allergy care through molecular precision. He has authored over 1,000 publications, holds more than 140 patents, and has an Hirsch index of 114 with 49,000 citations.

His honors include the International Distinguished Fellow Award (ACAAI), the Paul Ehrlich Award (EAACI), and the Erich Fuchs Award (DGAKI). He has served as Vice President of EAACI and President of the Austrian Society for Allergology and Immunology.

Currently, he directs major research initiatives at the Medical University of Vienna, including the Danube Allergy Research Cluster and the MCCA PhD program.

Professor Valenta has contributed to the development of molecular allergology in Romania and is supporting Romanian allergy research in the first RSACI project – EVALRO.

Back

Prof. Sophia Tsabouri

by aaaa îăîșț bbbb

Prof. Sophia Tsabouri

EAACI Chair of Pediatric Section. University Hospital of Ioannina, Greece

Prof. Sophia Tsabouri

Dr. Sophia Tsabouri is a Professor of Pediatric Allergy at the University Hospital of Ioannina, Greece, actively engaged in research and teaching since 2011.

She graduated in medicine in 1997 and specialized in Pediatric Allergy at St. Thomas’ Hospital, London, and Penteli Children’s Hospital, Athens. In 2011, she obtained the ESPACI Diploma in Pediatric Allergy, and in 2023, she was appointed Professor.

Her research interests include atopic dermatitis, drug allergies, anaphylaxis, and the genetics of allergic diseases. She has led major research projects, including Horizon 2020 – Stance4Health, and has published over 200 articles, with an Hirsch index of 28.

Prof. Sophia Tsabouri currently serves as the Chair of the Pediatric Section of the European Academy of Allergy and Clinical Immunology (EAACI) for the 2024–2026 term. Previously, she held the position of Secretary of the same section since 2008.

Back

Prof. Maria Torres

by aaaa îăîșț bbbb

Prof. Maria Torres

President of the European Academy of Allergy and Clinical Immunology (EAACI). Head of the Allergy Unit and Allergy Research Group at the Hospital Regional Universitario de Málaga, Spain.

Prof. Maria Torres

Prof. Maria Torres (Maria Jose Torres Jaén) is a leading expert in drug allergy and clinical immunology. In June 2024, she was appointed President of the European Academy of Allergy and Clinical Immunology (EAACI), becoming the first Spanish professional to hold this prestigious position. She is a Full Professor of Medicine at the University of Málaga and serves as the Head of the Allergy Department at the Malaga Regional University Hospital, where her team provides care for a population of over 1.5 million people.

Her clinical and research work is primarily focused on drug hypersensitivity, food allergy, and respiratory diseases. She leads a multidisciplinary research group of over 30 experts at IBIMA-Plataforma BIONAND, exploring precision medicine and predictive models for allergic reactions. Prof. Torres has authored over 180 scientific publications, serves as a Deputy Editor for the journal Allergy, and has coordinated numerous national and European research initiatives, including projects on the impact of climate change and artificial intelligence on allergic rhinitis.

Back

Prof. Frank Siebenhaar

by aaaa îăîșț bbbb

Prof. Frank Siebenhaar

Charité – Universitätsmedizin Berlin, Germany. Head of Patient Care at the Institute of Allergology (IFA). Head of Preclinical Development at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP).

Prof. Frank Siebenhaar

Prof. Frank Siebenhaar is a distinguished dermatologist and allergist with a focus on mast cell biology and mast cell-mediated diseases. He currently serves as the Head of Patient Care at the Institute of Allergology, Charité – Universitätsmedizin Berlin, and leads preclinical development at the Fraunhofer Institute (ITMP IA) in Berlin. He received his medical degree from Johannes Gutenberg University Mainz in 2003 and completed a postdoctoral fellowship in Experimental Pathology and Immunology at Harvard Medical School (2007–2009).

His clinical and research expertise is centered on mastocytosis, chronic urticaria, angioedema, and autoinflammatory syndromes. Prof. Siebenhaar has authored over 200 scientific publications and is a key figure in international medical networks, serving as the Chair of the European Competence Network on Mastocytosis (ECNM) and President of the German Working Group of Dermatological Research (ADF). He is also an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and is heavily involved in clinical trials and the development of new diagnostic tools and treatments for mast cell disorders.

Back

Prof. Mohamed Shamji

by aaaa îăîșț bbbb

Prof. Mohamed Shamji

Imperial College London, United Kingdom. Professor of Immunology and Allergy. Head of the Immunomodulation and Tolerance Group.

Prof. Mohamed Shamji

Prof. Mohamed Shamji is a world-renowned clinical immunologist and Professor of Immunology and Allergy at Imperial College London. He serves as the Head of the Immunomodulation and Tolerance Group within the National Heart and Lung Institute (NHLI). He earned his PhD from Imperial College London and has since dedicated his career to understanding the mechanisms of allergen-specific immunotherapy (AIT) and the development of novel biomarkers for allergic diseases.

His research is internationally recognized, focusing on immune tolerance, regulatory T and B cells, and the efficacy of biologics in treating asthma and allergic rhinitis. Prof. Shamji has authored over 150 scientific publications and holds leadership roles within the European Academy of Allergy and Clinical Immunology (EAACI), where he has served as Chair of the Immunology Section and a member of the Executive Committee. He is actively involved in clinical trials and the translation of basic science into personalized treatments for allergic patients.

Back

Prof. Montserrat Alvaro Lozano

by aaaa îăîșț bbbb

Prof. Montserrat Alvaro Lozano

Head of the Department of Pediatric Allergy and Clinical Immunology, Hospital Sant Joan de Déu, Barcelona, Spain. Member of the EAACI Quality Committee.

Prof. Montserrat Alvaro Lozano

Prof. Montserrat Alvaro Lozano is a leading pediatric allergist and researcher based in Barcelona, Spain. She serves as the Head of the Department of Pediatric Allergy and Clinical Immunology at SJD Barcelona Children’s Hospital and leads the “Allergic Diseases in Childhood and Adolescence” Research Group at the Institut de Recerca Sant Joan de Déu (IRSJD). She obtained her medical degree from the Autonomous University of Barcelona and completed her specialization and Master’s in Pediatric Allergy and Clinical Immunology at the University of Barcelona.

Her clinical and research expertise focuses on pediatric allergic diseases, with a special emphasis on food allergies, oral immunotherapy, and asthma. She has been a key contributor to the EAACI guidelines on the management of IgE-mediated food allergy. Prof. Alvaro Lozano has held several leadership positions, including President of the Pediatric Section of the European Academy of Allergy and Clinical Immunology (EAACI) and Vice-President of the Spanish Society of Pediatric Clinical Immunology, Allergy and Asthma (SEICAP). She has published over 90 scientific papers and is actively involved in international medical education and accreditation.

Back

Prof. Emek Kocatürk

by aaaa îăîșț bbbb

Prof. Emek Kocatürk

Charité Universitätsmedizin Berlin, Germany / Koç University School of Medicine, Turkey. Researcher at the Institute of Allergology (IFA).

Prof. Emek Kocatürk

Prof. Emek Kocatürk Göncü is a highly distinguished dermatologist and researcher currently active at the Institute of Allergology, Charité Universitätsmedizin Berlin, and as a Professor at Koç University in Istanbul. She graduated from Hacettepe University Faculty of Medicine in 1999 and specialized in dermatology at Göztepe Training and Research Hospital. Her clinical and research expertise is centered on chronic urticaria, angioedema, atopic dermatitis, and pruritus.

She is a prominent figure in the international allergy community, serving as a steering committee member of the UCARE (Urticaria Centers of Reference and Excellence) network and holding leadership roles within the European Academy of Allergy and Clinical Immunology (EAACI). Her current work involves project management in translational research at Charité, focusing on treatment responses, hormonal influences on skin diseases, and patient-reported outcomes. With over 170 scientific publications and a significant Hirsch index, she is a leading expert in the management of complex allergic skin conditions.

Back

Prof. Gülfem Elif Çelik

by aaaa îăîșț bbbb

Prof. Gülfem Elif Çelik

Ankara University Faculty of Medicine, Turkey Executive Board Member, European Academy of Allergy and Clinical Immunology (EAACI)

Gülfem Elif Çelik

Prof. Gülfem Elif Çelik is a senior allergist and immunologist with a distinguished career at Ankara University Faculty of Medicine, where she worked from 1997 to 2023. She received her medical degree from Hacettepe University and completed fellowships in pulmonary medicine and allergy, with a thesis on aspirin-induced asthma. She became a full professor in 2008 and served as Vice Dean (2012–2017) and Dean (2017–2021), leading initiatives in medical education and accreditation.

Her research focuses on asthma, drug allergy, and aspirin hypersensitivity. She has authored over 80 scientific publications and has an Hirsch index of 28. Internationally, she trained at Johns Hopkins, Harvard Medical School, and Lodz Medical University.

Prof. Çelik is a member of the EAACI Executive Committee and the Biologics Working Group. She currently coordinates the Turkish Adult Asthma Registry and practices in a private clinic, continuing to contribute actively to allergy care and research.

Back
Close